Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022

SELL
$23.0 - $29.01 $47,794 - $60,282
-2,078 Closed
0 $0
Q2 2021

Aug 12, 2021

BUY
$27.43 - $32.7 $6,254 - $7,455
228 Added 12.32%
2,078 $61,000
Q4 2020

Feb 08, 2021

SELL
$15.31 - $21.12 $26,792 - $36,960
-1,750 Reduced 48.61%
1,850 $38,000
Q3 2020

Oct 30, 2020

SELL
$14.88 - $20.13 $28,495 - $38,548
-1,915 Reduced 34.72%
3,600 $56,000
Q2 2020

Jul 27, 2020

BUY
$13.31 - $20.51 $25,488 - $39,276
1,915 Added 53.19%
5,515 $66,000
Q2 2019

Aug 07, 2019

BUY
$20.52 - $26.45 $71,820 - $92,575
3,500 Added 3500.0%
3,600 $91,000
Q1 2019

May 13, 2019

SELL
$20.23 - $26.29 $5,057 - $6,572
-250 Reduced 71.43%
100 $2,000
Q3 2018

Nov 14, 2018

BUY
$20.64 - $25.67 $7,224 - $8,984
350 New
350 $9,000

Others Institutions Holding BHC

About Bausch Health Companies Inc.


  • Ticker BHC
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 361,728,000
  • Market Cap $2.82B
  • Description
  • Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...
More about BHC
Track This Portfolio

Track Jacobi Capital Management LLC Portfolio

Follow Jacobi Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jacobi Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jacobi Capital Management LLC with notifications on news.